Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota
Intestinal mucosal inflammation and epithelial barrier dysfunction have been implicated as pathological factors in inflammatory bowel disease (IBD). An emerging area of IBD research focuses on probiotics. The probiotic Escherichia coli Nissle 1917 (EcN) is an excellent choice for engineering therape...
Main Authors: | Guigen Teng, Zilin Liu, Yun Liu, Ting Wu, Yun Dai, Huahong Wang, Weihong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.819336/full |
Similar Items
-
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Evaluation of E. coli Nissle1917 derived metabolites in modulating key mediator genes of the TLR signaling pathway
by: Sheyda Damoogh, et al.
Published: (2021-04-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda ALTUNTAŞ, et al.
Published: (2017-12-01)